The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine-Reference-Cited by-同舟云学术

The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine

Published:2008-06-09 Issue:1 Volume:105 Page:245-254
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Liu Angen,Yoshioka Ken-ichi,Salerno Vincenzo,Hsieh Peggy

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity;An;Cancer Res,2007

2. Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts;Andersen;Carcinogenesis,2005

3. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1;Bellacosa;Proc Natl Acad Sci USA,1999

4. Microsatellite instability and colorectal cancer prognosis;Benatti;Clin Cancer Res,2005

5. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine;Berry;Cancer Res,2000

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of mismatch repair enhances resistance to methylating agents for cells deficient in oxidative demethylation;Journal of Biological Chemistry;2024-08

2. REV3 promotes cellular tolerance to 5-fluorodeoxyuridine by activating translesion DNA synthesis and intra-S checkpoint;PLOS Genetics;2024-07-02

3. Enterohemorrhagic Escherichia coli effector EspF triggers oxidative DNA lesions in intestinal epithelial cells;Infection and Immunity;2024-04-09

4. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells;Expert Opinion on Therapeutic Targets;2023-10-03

5. Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods;BMC Cancer;2022-11-10